Diffuse Large B-Cell Lymphoma (DLBCL) Latest Advances
Find the Latest Research About Diffuse Large B-Cell Lymphoma (DLBCL)
Last Updated: 04/28/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9855 publications
Integrating Epstein-Barr virus (EBV) status into diffuse large B cell lymphoma (DLBCL) genetics.
Journal: bioRxiv : the preprint server for biology
Published: April 10, 2026
Suspected Secondary Intraocular Lymphoma With Choroidal Involvement Following Testicular Diffuse Large B-cell Lymphoma: A Case Report.
Journal: Cureus
Published: April 07, 2026
Cost-efficiency modeling of conversion to biosimilar rituximab-based R-CHOP in diffuse large B-cell lymphoma in medicare.
Journal: Journal of medical economics
Published: April 06, 2026
Clinical Characteristics and Outcome of Diffuse Large B-Cell Lymphoma: Real-World Data From Saudi Arabia.
Journal: JCO global oncology
Published: April 03, 2026
Isoform-Specific Functions of p73 Drive Survival and Chemoresistance in Diffuse Large B-Cell Lymphoma.
Journal: bioRxiv : the preprint server for biology
Published: April 03, 2026
Corrigendum to "Tumor-homing exosomes enable targeted delivery of siRNA and isoimperatorin for overcoming BTK inhibitor resistance in DLBCL" [Mater. Today Bio (35) 102267].
Journal: Materials today. Bio
Published: April 02, 2026
Primary sinonasal DLBCL: High prevalence of MCD subtype and CNS risk.
Journal: Annals of the Academy of Medicine, Singapore
Published: April 01, 2026
CGE26-139: Genomic Signatures of CNS and Systemic Relapse in Diffuse Large B-Cell Lymphoma (DLBCL) Patients Profiled With Next Generation Sequencing (NGS).
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: April 01, 2026
BPI26-014: Predictors of Advanced-Stage DLBCL at Diagnosis: Logistic Regression Analysis Highlights High Risk Populations With Inclusion of Demographic and Anatomic Risk Factors.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: April 01, 2026
Survival and prognostic features of early-stage diffuse large B-cell lymphoma in older adults.
Journal: Hematology (Amsterdam, Netherlands)
Published: April 01, 2026
CD83 as a novel prognostic biomarker for diffuse large B-cell lymphoma arising in immune deficiency/dysregulation among rheumatoid arthritis patients treated with methotrexate.
Journal: Journal of clinical and experimental hematopathology : JCEH
Published: April 01, 2026
CD5-positive diffuse large B-Cell lymphoma presenting with protein-losing enteropathy.
Journal: Journal of clinical and experimental hematopathology : JCEH
Published: April 01, 2026
Last Updated: 04/28/2026